Certified by Founder Lodge
Rock Springs Capital
United States - Baltimore, Maryland
INVESTOR
1 Disclosed Funding Rounds $135,000,000
6 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Rock Springs Capital is an investment firm that manages long-biased, healthcare-focused public equity funds.
Company | Date | Round | Raised |
---|---|---|---|
Hemab Therapeutics | February, 22 ,2023 | Series B | $135,000,000 |
Genesis Therapeutics | August, 22 ,2023 | Series B | $200,000,000 |
Apollo Therapeutics | September, 11 ,2023 | Series C | $226,500,000 |
Avalyn Pharma Inc. | September, 28 ,2023 | Series C | $175,000,000 |
FogPharma | March, 05 ,2024 | Series E | $145,000,000 |
Arsenal Biosciences, Inc. | September, 04 ,2024 | Series C | $325,000,000 |